Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Psychol Med. 2020 Nov 23;52(12):2299–2308. doi: 10.1017/S0033291720004201

Table 1.

Baseline demographics and clinical ratings

FEP (N = 43) HC (N = 35)
Characteristic Mean s.d. N Mean s.d. N T2 p value
Age (years) 22.37 4.66 22.22 3.52 −0.156 0.8765
Sex 0.026 0.8721
 Males 29 23
 Females 14 12
IQ (WASI) 105.09 13.42 108.03 8.88 1.159 0.2503
MCCB (total) 37.59 15.75 49.57 6.33 4.374 0.00006
Percent correct
 Load 1 82.12 13.93 91.61 7.34 −3.856 0.00026
 Load 3 67.51 14.99 76.70 10.97 −3.120 0.00256
Reaction time (seconds)
 Load 1 1053.92 158.52 973.46 191.75 1.990 0.05077
 Load 3 1119.14 191.81 1076.67 203.60 0.940 0.3502
#Antipsychotic naive NA
BPRS (total) 45.29 8.87 NA
BPRS (psychotic symptoms) 8.81 2.90 NA
BPRS (negative symptoms) 6.76 2.68 NA
Mean antipsychotic dosage (chlorpromazine equivalent in mg) 152.4 101.6 NA